Anavex Life Sciences (GB:0HFR)
LSE:0HFR

Anavex Life Sciences (0HFR) Income Statement

0 Followers

Anavex Life Sciences Income Statement

Last quarter (Q2 2023), Anavex Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Anavex Life Sciences's net income was $-13.11M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
--$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 26.55M$ 50.99M$ 41.95M$ 30.94M$ 28.81M$ 19.18M
Operating Income
$ -57.32M$ -50.99M$ -41.95M$ -30.94M$ -28.81M$ -19.18M
Net Non Operating Interest Income Expense
$ 2.94M$ 3.32M$ 26.26K$ 179.97K$ 56.15K$ 224.15K
Other Income Expense
$ 449.15K-$ 4.28M$ 4.50M$ 2.54M$ 1.78M
Pretax Income
$ -52.41M$ -47.62M$ -37.64M$ -26.26M$ -26.21M$ -17.18M
Tax Provision
$ 328.67K$ 358.49K$ 267.56K$ 22.66K$ 82.18K$ 72.75K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -52.74M$ -47.98M$ -37.91M$ -26.28M$ -26.29M$ -17.25M
Basic EPS
$ -0.34-$ -0.54$ -0.45$ -0.54$ -0.39
Diluted EPS
$ -0.34-$ -0.54$ -0.45$ -0.54$ -0.39
Basic Average Shares
$ 155.40M-$ 69.80M$ 58.19M$ 48.91M$ 44.66M
Diluted Average Shares
$ 155.40M-$ 69.80M$ 58.19M$ 48.91M$ 44.66M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 26.55M$ 50.99M$ 41.95M$ 30.94M$ 28.81M$ 19.18M
Net Income From Continuing And Discontinued Operation
$ -52.74M$ -47.98M$ -37.91M$ -26.28M$ -26.29M$ -17.25M
Normalized Income
$ -25.92M-$ -37.71M$ -26.37M$ -26.35M$ -17.22M
Interest Expense
------
EBIT
$ -57.07M$ -51.89M$ -41.95M$ -30.94M$ -28.81M$ -19.18M
EBITDA
$ -57.07M$ -51.89M$ -41.95M$ -30.94M$ -28.81M$ -19.18M
Currency in USD

Anavex Life Sciences Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis